Clinical trials and evaluation of AI tools in solid organ transplantation: implications for clinical care, regulatory science, and rare diseases.
Where this comes from
- Record sourced from PubMed, PMID 42414473.
- Also identified by DOI 10.1038/s41746-026-02963-1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Artificial Intelligence (AI) has widespread applications in solid organ transplantation (SOT), a field that fundamentally depends on optimizing complex paradigms across the continuum of care-from organ allocation to post-transplant management. However, only a minority have been tested through clinical trials. This perspective aims to synthesize the literature, identify gaps, and future directions for clinical trials of AI tools in SOT and how they may inform applications in related contexts.